CN102337211B - cell culture device - Google Patents
cell culture device Download PDFInfo
- Publication number
- CN102337211B CN102337211B CN 201110246683 CN201110246683A CN102337211B CN 102337211 B CN102337211 B CN 102337211B CN 201110246683 CN201110246683 CN 201110246683 CN 201110246683 A CN201110246683 A CN 201110246683A CN 102337211 B CN102337211 B CN 102337211B
- Authority
- CN
- China
- Prior art keywords
- electrode
- cell culture
- nerve
- optical fiber
- conduit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004113 cell culture Methods 0.000 title claims abstract description 72
- 210000005036 nerve Anatomy 0.000 claims abstract description 78
- 230000033228 biological regulation Effects 0.000 claims abstract description 27
- 210000003050 axon Anatomy 0.000 claims abstract description 15
- 230000001537 neural effect Effects 0.000 claims abstract description 15
- 230000000638 stimulation Effects 0.000 claims abstract description 15
- 239000013307 optical fiber Substances 0.000 claims description 48
- 239000003814 drug Substances 0.000 claims description 45
- 229940079593 drug Drugs 0.000 claims description 42
- 230000010412 perfusion Effects 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 230000012010 growth Effects 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000002699 waste material Substances 0.000 claims description 6
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 4
- 239000010703 silicon Substances 0.000 claims description 4
- 235000012239 silicon dioxide Nutrition 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 229910052814 silicon oxide Inorganic materials 0.000 claims description 4
- -1 Oxysiloxane Chemical class 0.000 claims description 3
- 238000004891 communication Methods 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000000206 photolithography Methods 0.000 claims description 3
- 238000004544 sputter deposition Methods 0.000 claims description 3
- 239000004020 conductor Substances 0.000 claims description 2
- 238000011897 real-time detection Methods 0.000 claims 1
- 210000002569 neuron Anatomy 0.000 abstract description 45
- 238000005516 engineering process Methods 0.000 abstract description 7
- 238000001514 detection method Methods 0.000 abstract description 6
- 230000002123 temporal effect Effects 0.000 abstract description 6
- 230000005284 excitation Effects 0.000 abstract description 5
- 230000005764 inhibitory process Effects 0.000 abstract description 5
- 230000010261 cell growth Effects 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 108090000623 proteins and genes Proteins 0.000 description 9
- 238000010586 diagram Methods 0.000 description 6
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 6
- 238000010276 construction Methods 0.000 description 4
- 239000002858 neurotransmitter agent Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000003575 carbonaceous material Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- HTXDPTMKBJXEOW-UHFFFAOYSA-N dioxoiridium Chemical compound O=[Ir]=O HTXDPTMKBJXEOW-UHFFFAOYSA-N 0.000 description 3
- 229960003638 dopamine Drugs 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 229910000457 iridium oxide Inorganic materials 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 108091006146 Channels Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229920001940 conductive polymer Polymers 0.000 description 2
- 230000002964 excitative effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 208000014094 Dystonic disease Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 101000903581 Natronomonas pharaonis Halorhodopsin Proteins 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000007072 Nerve Growth Factors Human genes 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- NRTOMJZYCJJWKI-UHFFFAOYSA-N Titanium nitride Chemical compound [Ti]#N NRTOMJZYCJJWKI-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 208000010118 dystonia Diseases 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 201000006517 essential tremor Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000005459 micromachining Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007996 neuronal plasticity Effects 0.000 description 1
- 239000003900 neurotrophic factor Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/04—Flat or tray type, drawers
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Sustainable Development (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Clinical Laboratory Science (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
本发明涉及一种细胞培养装置包括:固定底板及设在固定底板上的细胞培养系统、光调控系统和电极系统。该细胞培养装置通过微流控技术的特定结构来实现神经细胞的培养,如神经细胞可以生长在细胞培养室中,而轴突却只能生长在神经导管中,培养室中的神经细胞通过神经导管中的轴突构成神经环路,细胞生长区域的重现性和控制力相对较强;再通过激光对神经细胞进行高时空分辨率的调控,选择性和特异性强,可以实现对神经细胞的兴奋和抑制;通过电极系统刺激对神经环路进行辅助调控,并对神经环路的行为和功能进行实时检测,时空分辨率高,调控及检测结果可靠。
The invention relates to a cell culture device comprising: a fixed bottom plate, a cell culture system, a light control system and an electrode system arranged on the fixed bottom plate. The cell culture device achieves the culture of nerve cells through the specific structure of microfluidic technology. For example, nerve cells can grow in the cell culture chamber, but axons can only grow in the nerve conduit. The nerve cells in the culture chamber pass through the nerve cells. The axons in the catheter constitute the nerve loop, and the reproducibility and control of the cell growth area are relatively strong; and then the nerve cells are regulated with high spatio-temporal resolution by laser, which has strong selectivity and specificity, and can realize the control of nerve cells. The excitation and inhibition of the neural circuit are assisted by electrode system stimulation, and the behavior and function of the neural circuit are detected in real time, with high spatial and temporal resolution, and reliable regulation and detection results.
Description
【技术领域】 【Technical field】
本发明涉及神经工程领域,尤其涉及一种基于微流控技术的细胞培养装置。The invention relates to the field of neural engineering, in particular to a cell culture device based on microfluidic technology.
【背景技术】 【Background technique】
随着神经系统疾病发病率的不断上升,对它的研究正逐渐成为热点。然而,由于神经系统的复杂性,使得在活体(in vivo)研究神经系统的某些问题,尤其是对于神经环路以及神经可塑性的探索非常困难。在这种条件下,神经细胞的体外(in vitro)培养就成为了一种较为理想的方法。可以通过体外培养使神经细胞之间建立规则的联系,将神经元之间复杂的三维联系降低到二维,使得其观察和研究更加容易。With the increasing incidence of nervous system diseases, its research is gradually becoming a hot spot. However, due to the complexity of the nervous system, it is very difficult to study some problems of the nervous system in vivo, especially the exploration of neural circuits and neural plasticity. Under such conditions, in vitro culture of nerve cells has become an ideal method. Regular connections between neurons can be established through in vitro culture, and the complex three-dimensional connections between neurons can be reduced to two dimensions, making observation and research easier.
传统的神经细胞体外培养的方法是在培养基体上通过表面化学处理(Chemically pattemed surface)、物理微观结构构建(Physical structure)或者溶液浓度梯度(Solution gradients)来调控神经细胞的生长,使之形成神经环路,然后通过功能性电刺激(Functional electrical stimulation)或者局部灌注(Localperfusion)来调控神经细胞。The traditional method of culturing nerve cells in vitro is to regulate the growth of nerve cells on the culture medium through chemically patterned surface, physical microstructure construction (Physical structure) or solution gradients (Solution gradients) to form nerve cells. circuit, and then regulate nerve cells through functional electrical stimulation (Functional electrical stimulation) or local perfusion (Local perfusion).
其中,表面化学处理是通过化学方法将细胞培养基体表面处理成具有一定形状的生物相容性界面,从而吸引神经细胞在这些区域生长;物理微观结构构建是通过微加工技术,将细胞培养基体表面处理成具有一定微观结构的界面,引导神经细胞在指定区域生长;溶液浓度梯度是通过控制生物活性物质(如多肽、蛋白)的浓度来影响神经细胞在一定区域内的生长。功能性电刺激是目前已经用于临床的一种调控方式,在对于原发性震颤、帕金森症和肌张力障碍等疾病的治疗中起到了较好的作用。Among them, the surface chemical treatment is to chemically treat the surface of the cell culture substrate into a biocompatible interface with a certain shape, so as to attract nerve cells to grow in these areas; It is processed into an interface with a certain microstructure to guide the growth of nerve cells in a designated area; the concentration gradient of the solution is to affect the growth of nerve cells in a certain area by controlling the concentration of biologically active substances (such as polypeptides and proteins). Functional electrical stimulation is a regulation method that has been used clinically, and it has played a good role in the treatment of diseases such as essential tremor, Parkinson's disease and dystonia.
然而,通过表面化学处理、物理微观结构构建或者化学浓度梯度来调控神经细胞的生长以形成神经环路,细胞生长区域的重现性和控制力相对较差,从而实验的重现性较差。功能性电刺激虽然有优异的时间分辨率,但是它的空间分辨率较差,并且不具备选择性和特异性,较难实现对神经细胞的抑制。局部灌注虽然具有较高的空间分辨率,但是灌注的位置随意性较大,很难精确控制,重现性较差;此外,局部灌注的时间分辨率较差,无法满足电生理要求。因此,传统的缺少一种可同时用于神经细胞培养,神经环路构建,以及在较高时空分辨率(Spatiotemporal resolution)下进行调控、检测的细胞培养装置。However, by regulating the growth of nerve cells to form neural circuits through surface chemical treatment, physical microstructure construction or chemical concentration gradients, the reproducibility and control of the cell growth area is relatively poor, so the reproducibility of the experiment is poor. Although functional electrical stimulation has excellent time resolution, its spatial resolution is poor, and it is not selective and specific, making it difficult to inhibit nerve cells. Although local perfusion has high spatial resolution, the position of perfusion is random, it is difficult to control accurately, and the reproducibility is poor; in addition, the temporal resolution of local perfusion is poor, which cannot meet the electrophysiological requirements. Therefore, there is a traditional lack of a cell culture device that can be used for nerve cell culture, neural circuit construction, and regulation and detection at a higher spatiotemporal resolution.
【发明内容】 【Content of invention】
基于此,有必要提供一种可同时用于神经细胞培养,神经环路构建,以及在较高时空分辨率下进行调控、检测的细胞培养装置。Based on this, it is necessary to provide a cell culture device that can be used for nerve cell culture, neural circuit construction, regulation and detection at a higher spatio-temporal resolution.
一种细胞培养装置包括:固定底板及设在固定底板上的细胞培养系统、光调控系统和电极系统;细胞培养系统包括细胞培养室及连通细胞培养室的供神经轴突生长的神经导管;光调控系统置于神经导管上方用于对神经导管内的培养物进行光刺激调控;电极系统与神经导管相通用于对神经导管内培养物进行辅助调控,并对神经环路的行为和功能进行实时检测。A cell culture device includes: a fixed base plate and a cell culture system arranged on the fixed base plate, a light regulation system and an electrode system; The control system is placed above the nerve conduit to regulate the photostimulation of the culture in the nerve conduit; the electrode system communicates with the nerve conduit to assist in the regulation of the culture in the nerve conduit, and to monitor the behavior and function of the neural circuit in real time. detection.
应用于上述方案,优选的,该细胞培养装置还包括固定在固定底板上的药物灌注系统,药物灌注系统包括药物灌注池、药物导管及废液池,药物灌注池通过药物导管与废液池相连,药物导管与神经导管相连通。Applied to the above scheme, preferably, the cell culture device also includes a drug perfusion system fixed on the fixed base plate, the drug perfusion system includes a drug perfusion pool, a drug catheter and a waste liquid pool, and the drug perfusion pool is connected to the waste liquid pool through a drug catheter , The drug conduit communicates with the nerve conduit.
应用于上述方案及其组合,优选的,其中电极系统包括外接触点、导线及电极点,外接触点通过导线与电极点相连,神经导管与电极点相通。Applied to the above scheme and its combination, preferably, the electrode system includes an external contact point, a wire and an electrode point, the external contact point is connected to the electrode point through a wire, and the nerve guide is connected to the electrode point.
应用于上述方案及其组合,优选的,其中电极点通过电化学方法沉积有导电材料用于降低电极点的阻抗,且电极点通过酶固定技术修饰有酶化合物用于采集生化信号。Applied to the above scheme and its combination, preferably, the electrode points are electrochemically deposited with conductive materials for reducing the impedance of the electrode points, and the electrode points are modified with enzyme compounds by enzyme immobilization technology for collecting biochemical signals.
应用于上述方案及其组合,优选的,其中电极系统通过溅射或光刻的方式形成在固定底板上。Applied to the above solutions and combinations thereof, preferably, the electrode system is formed on the fixed base plate by sputtering or photolithography.
应用于上述方案及其组合,优选的,其中光调控系统的光刺激位置与电极点的位置对应。Applied to the above solutions and combinations thereof, preferably, the light stimulation position of the light regulation system corresponds to the position of the electrode points.
应用于上述方案及其组合,优选的,其中光调控系统包括激光光源、光纤接口、光纤及用于控制激光光柱导向和直径的波导,波导通过光纤、光纤接口与激光光源相连。Applied to the above scheme and its combination, preferably, the light control system includes a laser light source, an optical fiber interface, an optical fiber, and a waveguide for controlling the guiding and diameter of the laser beam, and the waveguide is connected to the laser light source through the optical fiber and the optical fiber interface.
应用于上述方案及其组合,优选的,其中电极系统包括多个一一对应的外接触点、导线及电极点,多个外接触点围绕固定底板四周均匀分布,多个导线及电极点形成电极阵列,相应的,光调控系统包括多个不同直径的波导,多个波导形成波导阵列,波导阵列中波导的位置与电极阵列中电极点位置一一对应;电极阵列、波导阵列及药物导管中设有微流控开关。Applied to the above scheme and its combination, preferably, the electrode system includes a plurality of one-to-one corresponding external contact points, wires and electrode points, and the plurality of external contact points are evenly distributed around the fixed base plate, and the plurality of wires and electrode points form electrodes Correspondingly, the light control system includes a plurality of waveguides with different diameters, and the plurality of waveguides form a waveguide array, and the positions of the waveguides in the waveguide array correspond to the positions of the electrode points in the electrode array; There are microfluidic switches.
应用于上述方案及其组合,优选的,其中神经导管的宽度为1~10μm,长度为100~1000μm;波导的直经为1~10μm。Applied to the above solutions and combinations thereof, preferably, the nerve guide has a width of 1-10 μm and a length of 100-1000 μm; the waveguide has a straight diameter of 1-10 μm.
应用于上述方案及其组合,优选的,其中细胞培养系统包括两组细胞培养室,每组包括两个连通的细胞培养室,两组细胞培养室之间通过4个神经导管连通,神经导管的直径为5μm,长度为900μm;电极系统沿每个神经导管的轴向依次设有16个方形电极点,电极点的长宽均为5μm,每个神经导管轴向的电极点之间相距50μm;光调控系统包括16个波导,波导的直径为2μm;药物灌注系统包括多个与神经导管正交连通的药物导管。Applied to the above scheme and its combination, preferably, wherein the cell culture system includes two sets of cell culture chambers, each group includes two connected cell culture chambers, the two groups of cell culture chambers are connected through 4 nerve conduits, and the nerve conduits The diameter is 5 μm and the length is 900 μm; the electrode system is provided with 16 square electrode points along the axial direction of each nerve guide, the length and width of the electrode points are both 5 μm, and the distance between the electrode points in the axial direction of each nerve guide is 50 μm; The light regulation system includes 16 waveguides, and the diameter of the waveguide is 2 μm; the drug perfusion system includes a plurality of drug conduits orthogonally connected to the nerve conduits.
应用于上述方案及其组合,优选的,其中光调控系统包括激光光源、光纤接口、分接口和光纤,光纤通过分接口、光纤接口与激光光源相连。Applied to the above solutions and combinations thereof, preferably, the light control system includes a laser light source, an optical fiber interface, a sub-interface and an optical fiber, and the optical fiber is connected to the laser light source through the sub-interface and the optical fiber interface.
应用于上述方案及其组合,优选的,其中电极系统包括多个一一对应的外接触点、导线及电极点,多个外接触点围绕固定底板四周均匀分布,多个导线及电极点形成电极阵列,相应的,光调控系统包括多个不同直径的光纤,多个光纤形成光纤阵列,光纤阵列中光纤的位置与电极阵列中电极点位置一一对应;电极阵列、波导阵列及药物导管中设有微流控开关。Applied to the above scheme and its combination, preferably, the electrode system includes a plurality of one-to-one corresponding external contact points, wires and electrode points, and the plurality of external contact points are evenly distributed around the fixed base plate, and the plurality of wires and electrode points form electrodes Correspondingly, the light control system includes a plurality of optical fibers with different diameters, and a plurality of optical fibers form an optical fiber array, and the positions of the optical fibers in the optical fiber array correspond to the positions of the electrode points in the electrode array; There are microfluidic switches.
应用于上述方案及其组合,优选的,其中神经导管的宽度为1~10μm,长度为100~1000μm;光纤的直经为1~10μm。Applied to the above solutions and combinations thereof, preferably, the nerve conduit has a width of 1-10 μm and a length of 100-1000 μm; the straight diameter of the optical fiber is 1-10 μm.
应用于上述方案及其组合,优选的,其中细胞培养系统包括两组细胞培养室,每组包括两个连通的细胞培养室,两组细胞培养室之间通过4个神经导管连通,神经导管的直径为5μm,长度为900μm;电极系统沿每个神经导管的轴向依次设有16个方形电极点,电极点的长宽均为5μm,每个神经导管轴向的电极点之间相距50μm;光调控系统包括16个光纤,光纤的直径为2μm;药物灌注系统包括多个与神经导管正交连通的药物导管。Applied to the above scheme and its combination, preferably, wherein the cell culture system includes two sets of cell culture chambers, each group includes two connected cell culture chambers, the two groups of cell culture chambers are connected through 4 nerve conduits, and the nerve conduits The diameter is 5 μm and the length is 900 μm; the electrode system is provided with 16 square electrode points along the axial direction of each nerve guide, the length and width of the electrode points are both 5 μm, and the distance between the electrode points in the axial direction of each nerve guide is 50 μm; The light control system includes 16 optical fibers with a diameter of 2 μm; the drug perfusion system includes a plurality of drug conduits orthogonally connected to the nerve conduits.
应用于上述方案及其组合,优选的,其中固定底板的材质为玻璃、硅或二氧化硅;细胞培养室及神经导管的材质为透明的聚二甲氧基硅氧烷。Applied to the above scheme and its combination, preferably, the material of the fixed bottom plate is glass, silicon or silicon dioxide; the material of the cell culture chamber and the nerve guide is transparent polydimethoxysiloxane.
该细胞培养装置通过微流控技术的特定结构来实现神经细胞的培养,如神经细胞可以生长在细胞培养室中,而轴突却只能生长在神经导管中,培养室中的神经细胞通过神经导管中的轴突构成神经环路,细胞生长区域的重现性和控制力相对较强;再通过激光对神经细胞进行高时空分辨率的调控,选择性和特异性强,可以实现对神经细胞的兴奋和抑制;通过电极系统刺激对神经环路进行辅助调控,并对神经环路的行为和功能进行实时检测,时空分辨率高,调控及检测结果可靠。The cell culture device achieves the culture of nerve cells through the specific structure of microfluidic technology. For example, nerve cells can grow in the cell culture chamber, but axons can only grow in the nerve conduit. The nerve cells in the culture chamber pass through the nerve cells. The axons in the catheter constitute the nerve loop, and the reproducibility and control of the cell growth area are relatively strong; and then the nerve cells are regulated with high spatio-temporal resolution by laser, which has strong selectivity and specificity, and can realize the control of nerve cells. The excitation and inhibition of the neural circuit are assisted by electrode system stimulation, and the behavior and function of the neural circuit are detected in real time, with high spatial and temporal resolution, and reliable regulation and detection results.
【附图说明】 【Description of drawings】
图1为一实施方式的细胞培养装置结构示意图;1 is a schematic structural view of a cell culture device according to an embodiment;
图2为图1实施方式中细胞培养系统结构示意图;Fig. 2 is a schematic structural diagram of the cell culture system in the embodiment of Fig. 1;
图3为图1实施方式中电极阵列与神经导管分布示意图;Fig. 3 is a schematic diagram of the distribution of the electrode array and the nerve guide in the embodiment of Fig. 1;
图4为图1实施方式中细胞培养系统与药物灌注系统分布示意图;Fig. 4 is a schematic diagram of the distribution of the cell culture system and the drug perfusion system in the embodiment of Fig. 1;
图5为图1实施方式中神经导管与药物导管分布示意图;Fig. 5 is a schematic diagram of the distribution of nerve guides and drug guides in the embodiment of Fig. 1;
图6为图1实施方式中光调控系统与细胞培养系统分布示意图;Fig. 6 is a schematic diagram of the distribution of the light regulation system and the cell culture system in the embodiment of Fig. 1;
图7为另一实施方式的光调控系统与细胞培养系统分布示意图。Fig. 7 is a schematic diagram of the distribution of the light regulation system and the cell culture system according to another embodiment.
【具体实施方式】 【Detailed ways】
下面主要结合附图及具体实施例对细胞培养装置作进一步详细的说明。In the following, the cell culture device will be further described in detail mainly in conjunction with the accompanying drawings and specific examples.
如图1所示,一优选实施方式的细胞培养装置100包括:固定底板110、细胞培养系统120、电极系统130、药物灌注系统140及光调控系统(图未示)。其中,细胞培养系统120、电极系统130、药物灌注系统140及光调控系统固定在固定底板110上。As shown in FIG. 1 , a
固定底板110可以由硬质材料构成,主要起支撑固定的作用。可以选用的材料有玻璃、硅及二氧化硅等。本实施方式的固定底板110为方形玻璃底板。在其他实施方式中,固定底板110还可以采用其他材料如硅或二氧化硅制作,形状也不限于方形,还可以为圆形等。The fixed
请参图2,本实施方式的细胞培养系统120包括两组共4个细胞培养室122。每组细胞培养室之间通过主导管124连通。两组之间的主导管124通过设在主导管124上的4个神经导管126连通。神经导管126连通两主导管124,从而两组细胞培养室122可以通过神经导管126连通。细胞培养室122和神经导管126主要用于控制和引导神经细胞的生长和神经细胞之间的连接以及神经环路的形成。可以根据需要的研究模型进行设计不同规格的神经导管126,神经导管126的宽度为1~10μm,长度为100~1000μm。优选的,本实施方式的神经导管的宽度为5μm,长度为900μm,这种设计的神经导管126可以保证神经细胞不会进入到神经导管126中,而只有轴突在神经导管126中生长,从而可以得到有序的神经网络。Referring to FIG. 2 , the
细胞培养系统120优选柔性透明的透气性较好的材料制作,如硅橡胶等。本实施方式的细胞培养系统采用具有高度疏水性的聚二甲氧基硅氧烷(PDMS)制作。为使神经细胞在细胞培养室122中更好的生长,本实施方式的细胞培养室122、主导管124及神经导管126的内表面可以通过表面嫁接、表面涂膜、层层自组装等技术进行生物相容性处理。此外,在细胞培养前,细胞培养室122、主导管124及神经导管126的内表面进一步还可以进行包被处理,如多聚赖氨酸包被、层粘连蛋白包被等。The
请结合图1和图3,电极系统130包括外接触头132、导线134及电极点136。外接触头132通过导线134与电极点136连接,每个外接触头132对应一个电极点136。多个外接触头132围绕固定底板110的四周均匀设置,多个导线134及电极点136形成电极阵列。本实施方式的固定底板110的每条边设有16个外接触点132。为进一步方便使用,外接触点132的设计使之可以直接连接到通用的电生理测量仪器上进行电生理测量,如美国Plexon公司和德国MEA公司的电生理测量仪。神经导管126的轴向依次排列有由16个导线134及方形电极点136形成的电极阵列,每个电极点136的长宽均为5μm,每两个电极点136之间间隔50μm。神经导管126与电极点136相通,从而电极阵列可以对神经导管126内的培养物进行高时空分辨率的电生理测量和电脉冲刺激。Please refer to FIG. 1 and FIG. 3 , the
优选的,本实施方式的电极系统130是通过溅射或光刻的方式形成在固定底板110的表面。导线134及电极点136的材料可以为金、铂、氧化铱、氮化钛、导电聚合物、碳基材料中的一种或者两种以上。在实际使用过程中,电极系统130可以作为一种辅助的调控方式,电极阵列可以对神经细胞进行功能性电脉冲刺激,通过改变在微环境中的电场强度来对神经细胞的生长进行诱导,并能对神经环路和神经可塑性进行研究。为降低电极点136的接触阻抗,增强电生理信号的信噪比,可以通过电化学方法在电极点136的表面沉积修饰材料,如氧化铱、导电聚合物或碳基材料等。如对氧化铱材质的电极点136进行碳基材料的修饰后,可以在1KHz的测量频率下将电极点136的阻抗降低50%~90%,得到的电生理信号的背景噪音小,信噪比高。进一步,可以使用酶固定技术对电极点136进行酶化合物的固定修饰,以构成生物传感器对轴突周围的微环境进行检测,检测的信号包括神经递质的浓度、氨基酸浓度、离子浓度、氧浓度、温度、pH值等,从而得到轴突在调控过程中的神经递质、谷氨酸和重要离子浓度的变化,以及环境中氧气、温度和pH等重要指标的变化情况。例如可以对电极点136进行酪氨酸酶修饰后,可以得到神经传递质多巴胺传感器,采用该多巴胺传感器可以实现在一定空间范围内实施检测轴突位置释放的多巴胺浓度,从而可以研究神经环路的功能。Preferably, the
更进一步,可以通过在各电极阵列中设置微流控开关,可以针对性的打开或关闭相应的电极点136,选择性的对神经导管126进行局部的电脉冲刺激。Furthermore, by setting microfluidic switches in each electrode array, the corresponding electrode points 136 can be turned on or off in a targeted manner, and the
请结合图1、图4和图5,药物灌注系统140包括药物灌注池142、药物导管144及废液池146。药物灌注池142通过药物导管144与废液池146相连。药物导管144与神经导管126相连通,可以对神经导管126内的微环境中轴突进行药物刺激。所用的药物可以为神经营养因子、神经递质、氨基酸或基因(如光敏感型蛋白基因等)等。本实施方式的药物灌注系统140包括9个药物导管144。9个药物导管144与神经导管126正交连通。采用多个药物导管144可以对轴突进行多点药物刺激或者进行高通量的药物筛选,药物释放均匀,实验结果可靠。进一步,各药物导管144中可设置微流控开关,通过微流控开关打开或关闭相应的药物导管,可以针对性的对神经导管126内的轴突进行药物刺激。Please refer to FIG. 1 , FIG. 4 and FIG. 5 , the
如图6所示,光调控系统150设于细胞培养系统120的上方。光调控系统150包括激光光源(图未示)、光纤接口152、光纤154及用于控制激光光柱的导向和直径的波导156。波导156通过光纤154、光纤接口152与激光光源相连。波导156将激光光源发出的激光导入到神经导管126中,对轴突等进行光刺激调控。在实施过程中,激光光源主要发出蓝色(波长=472nm)或黄色(波长=593nm)激光,蓝色或黄色激光通过光纤154和波导156导入到神经导管126中进行照射。由于蓝色或黄色激光只对导入了光敏感基因的细胞起作用,因此该光调控系统150具有细胞特异性,并且能有效兴奋或抑制神经元。在使用光调控系统150之前,需要将光敏感基因通过特异的启动子转入到与相关回路的神经元内并表达。其中,兴奋型通道蛋白基因为Channelrhodopsin-2(ChR2),抑制型通道蛋白基因为Helorhodopsin(NpHR)。光调控系统150通过光纤154和波导156向神经导管内转有光敏感基因的神经元提供光刺激,由此引起神经元的兴奋或抑制。用蓝光刺激表达有兴奋型通道蛋白基因的神经元,将兴奋该类神经元;而用黄光刺激表达有抑制型通道蛋白基因的神经元,将抑制该类神经元。通过兴奋或抑制就能调控神经回路,从而进行相关的研究。由于光调控系统150具有细胞特异性,这种光敏感基因神经调控技术具有较高的时空分辨率。As shown in FIG. 6 , the
光调控系统150可以包括多个波导156,波导的直接可以为1~10μm。多个波导156通过微加工技术形成波导阵列。通过波导阵列可以将入射的激光分成具有固定大小的激光阵列,同时可以在波导阵列中加入微流控开关,可以选择性的进行局部的光刺激,目的性强,时空分辨率高。波导156引导激光的光刺激位点与电极点136的位置对应,从而电极点136可以较为准确针对性的采集光刺激位点的电生理信号。本实施方式的光调控系统150在每条神经导管126的轴向分布有16个波导156。波导156的直径为2μm。16个波导156与16个电极点136相对应。The
在其他实施方式中,光调控系统还可以通过设置不同直径的光纤替代波导。如图7所示,本实施方式中的光调控系统250包括激光光源(图未示)、光纤接口252、分接口254和光纤256。光纤256通过分接口254、光纤接口252与激光光源相连。光纤256的直径可以为1~10μm。优选的,光纤的直径为2μm。光纤256直接将激光光源发出的激光导入到神经导管126中。多个光纤256可以形成光纤阵列,光纤阵列中可以加入微流控开关,选择性的对神经导管126进行局部的光刺激。In other embodiments, the optical control system can also replace the waveguide by arranging optical fibers with different diameters. As shown in FIG. 7 , the light control system 250 in this embodiment includes a laser light source (not shown in the figure), an optical fiber interface 252 , a branch interface 254 and an optical fiber 256 . The optical fiber 256 is connected to the laser light source through the sub-port 254 and the optical fiber interface 252 . The diameter of the optical fiber 256 may be 1-10 μm. Preferably, the diameter of the optical fiber is 2 μm. The optical fiber 256 directly guides the laser light emitted by the laser light source into the
该细胞培养装置100通过微流控技术的特定结构来实现神经细胞的培养,如神经细胞可以生长在细胞培养室122中,而轴突却只能生长在神经导管126中,细胞培养室122中的神经细胞通过神经导管126中的轴突构成神经环路,细胞生长区域的重现性和控制力相对较强;再通过激光对神经细胞进行高时空分辨率的调控,选择性和特异性强,可以实现对神经细胞的兴奋和抑制;通过电极系统130刺激对神经环路进行辅助调控,并对神经环路的行为和功能进行实时检测,时空分辨率高,调控及检测结果可靠。The
以上所述实施例仅表达了本发明的几种实施方式,其描述较为具体和详细,但并不能因此而理解为对本发明专利范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干变形和改进,这些都属于本发明的保护范围。因此,本发明专利的保护范围应以所附权利要求为准。The above-mentioned embodiments only express several implementation modes of the present invention, and the description thereof is relatively specific and detailed, but should not be construed as limiting the patent scope of the present invention. It should be pointed out that those skilled in the art can make several modifications and improvements without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent for the present invention should be based on the appended claims.
Claims (11)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110246683 CN102337211B (en) | 2011-08-25 | 2011-08-25 | cell culture device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110246683 CN102337211B (en) | 2011-08-25 | 2011-08-25 | cell culture device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102337211A CN102337211A (en) | 2012-02-01 |
| CN102337211B true CN102337211B (en) | 2013-04-17 |
Family
ID=45513165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110246683 Active CN102337211B (en) | 2011-08-25 | 2011-08-25 | cell culture device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102337211B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103173355A (en) * | 2013-04-18 | 2013-06-26 | 中国医学科学院生物医学工程研究所 | Cell culture incubator with low-level laser environment |
| CN107758605B (en) * | 2016-08-16 | 2020-01-31 | 中国科学院上海微系统与信息技术研究所 | Microelectrode array chip and method of making the same |
| CN112587804A (en) * | 2020-12-25 | 2021-04-02 | 中国科学院重庆绿色智能技术研究院 | Peripheral nerve repair device combining light stimulation and nerve conduit technology |
| CN112662554B (en) * | 2020-12-31 | 2022-11-04 | 北京工业大学 | Microfluidic platform, preparation method and application thereof |
| CN114736802A (en) * | 2022-05-07 | 2022-07-12 | 北京理工大学 | A biological microfluidic channel for optimizing the directional growth of neural axons |
| CN115011463A (en) * | 2022-07-08 | 2022-09-06 | 西湖大学 | Cell regulation and control equipment |
| CN118222398B (en) * | 2024-05-09 | 2025-09-26 | 中国科学院空天信息创新研究院 | A microfluidic biointerconnected neural network chip and its preparation method |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1439432A (en) * | 2003-03-21 | 2003-09-03 | 东华大学 | Nervous duct and membrane with fixed nerve regeneration promoting agent with surface modified by plasma and their preparations |
| WO2007055178A1 (en) * | 2005-11-08 | 2007-05-18 | Japan Health Sciences Foundation | Method of cell fractionation and substrate to be used for the method |
| CN101748061A (en) * | 2008-12-15 | 2010-06-23 | 国家纳米科学中心 | Device for establishing single-cell level connection between neurons and growth connecting method |
| CN101912318A (en) * | 2010-07-30 | 2010-12-15 | 东华大学 | A three-layer electrospun ordered fiber nerve conduit and its preparation and application |
-
2011
- 2011-08-25 CN CN 201110246683 patent/CN102337211B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1439432A (en) * | 2003-03-21 | 2003-09-03 | 东华大学 | Nervous duct and membrane with fixed nerve regeneration promoting agent with surface modified by plasma and their preparations |
| WO2007055178A1 (en) * | 2005-11-08 | 2007-05-18 | Japan Health Sciences Foundation | Method of cell fractionation and substrate to be used for the method |
| CN101748061A (en) * | 2008-12-15 | 2010-06-23 | 国家纳米科学中心 | Device for establishing single-cell level connection between neurons and growth connecting method |
| CN101912318A (en) * | 2010-07-30 | 2010-12-15 | 东华大学 | A three-layer electrospun ordered fiber nerve conduit and its preparation and application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102337211A (en) | 2012-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102337211B (en) | cell culture device | |
| Shin et al. | 3D high-density microelectrode array with optical stimulation and drug delivery for investigating neural circuit dynamics | |
| He et al. | Nanoneedle platforms: the many ways to pierce the cell membrane | |
| JP4321962B2 (en) | Method for the electroosmosis of individual solid cell structures and organelle structures and uses thereof | |
| US9632076B2 (en) | Microfluidic device for generating neural cells to simulate post-stroke conditions | |
| Wang et al. | Single-cell electroporation | |
| Nolkrantz et al. | Electroporation of single cells and tissues with an electrolyte-filled capillary | |
| TWI598830B (en) | Formation and utilization of neural cell networks, and neural cell sowing devices | |
| CN100344960C (en) | Apparatus for irritating animal cell and recording its physiological signal and its production and using method | |
| CN108350606A (en) | Cell Culture, Shipping, and Exploration | |
| Fang et al. | Scalable and robust hollow nanopillar electrode for enhanced intracellular action potential recording | |
| CN114636744A (en) | Nanoporous membrane-based microelectrode array chip and high-throughput intracellular electrical signal continuous monitoring system | |
| Wang et al. | Nanopipette-based nanosensor for label-free electrochemical monitoring of cell membrane rupture under H2O2 treatment | |
| CN104490385A (en) | Needle type microelectrode array | |
| JP4370082B2 (en) | Neuron culture microchamber | |
| US10793820B2 (en) | Miniaturized, automated in-vitro tissue bioreactor | |
| Zhou et al. | Nanoelectrochemical architectures for high-spatial-resolution single cell analysis | |
| CN110582569B (en) | Methods and systems for functional maturation of iPSC- and ESC-derived cardiomyocytes | |
| Liu et al. | Toward the development of an artificial brain on a micropatterned and material-regulated biochip by guiding and promoting the differentiation and neurite outgrowth of neural stem/progenitor cells | |
| Zhang et al. | Single neurons on microelectrode array chip: manipulation and analyses | |
| CN119639575A (en) | Neuromuscular multi-element coupling organoid microfluidic chip, device and method | |
| CN103344903B (en) | A kind of neuro chip measurement mechanism of high-spatial and temporal resolution | |
| Sifringer et al. | An implantable biohybrid nerve model towards synaptic deep brain stimulation | |
| Frega | Neuronal network dynamics in 2D and 3D in vitro neuroengineered systems | |
| EP3413114B1 (en) | Functionalized optical lens and method of manufacturing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20241202 Address after: 210000 room b801, Kechuang headquarters building, 320 pubin Road, Nanjing area, Jiangsu Free Trade Zone, Nanjing City, Jiangsu Province Patentee after: Jiangsu Mingyang TuRui Technology Co.,Ltd. Country or region after: China Address before: 1068 No. 518055 Guangdong city in Shenzhen Province, Nanshan District City Xili University School Avenue Patentee before: SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES Country or region before: China |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20241203 Address after: Room 404-1, Building A, No. 4083 Jianshe Fourth Road, Xinjie Street, Xiaoshan District, Hangzhou City, Zhejiang Province (self declared) Patentee after: Zhejiang Yuanqi Future Biotechnology Co.,Ltd. Country or region after: China Address before: 210000 room b801, Kechuang headquarters building, 320 pubin Road, Nanjing area, Jiangsu Free Trade Zone, Nanjing City, Jiangsu Province Patentee before: Jiangsu Mingyang TuRui Technology Co.,Ltd. Country or region before: China |
|
| TR01 | Transfer of patent right |